Vybion Overview

  • Status
  • Private
  • Employees
  • 5
Employees
  • Latest Deal Type
  • Later Stage VC
  • Investors
  • 3

Vybion General Information

Description

Operator of a patented drug discovery platform intended to offer proteins for diagnostics and therapeutic drugs. The company's platform develops a therapy for Huntington's disease by providing a small antibody fragment that is effective in both cell-based systems and animal models, enabling healthcare professionals to deliver treatment for their patients and assist them in recovery.

Contact Information

Website
www.vybion.com
Formerly Known As
Viral Therapeutics
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
  • 33 Thornwood Drive
  • Suite 104
  • Ithaca, NY 14850
  • United States
+1 (607) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Vybion Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC Completed Generating Revenue
4. Grant 01-Nov-2010 00000 Completed Generating Revenue
3. Grant 03-Dec-2009 00000 Completed Generating Revenue
2. Grant 01-Jan-2009 $127K Completed Generating Revenue
1. Debt - General 30-Sep-2005 Completed Generating Revenue
To view Vybion’s complete valuation and funding history, request access »

Vybion Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Operator of a patented drug discovery platform intended to offer proteins for diagnostics and therapeutic drugs. The com
Drug Discovery
Ithaca, NY
5 As of 2021
00000 00000

00000 00

isi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit es
0000000000000
Pittsburgh, PA
0 As of 0000
00.000
0000000000 0 00.000

00000000

ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolor
0000 000000000
Singapore, Singapore
00.00
00.00 0000-00-00
000000000000 00.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Vybion Competitors (12)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Sharp Edge Labs Venture Capital-Backed Pittsburgh, PA 0 00.000 0000000000 0 00.000
000000000 Private Equity-Backed Singapore, Singapore 00.00 000000000000 00.00
0000 00000 0000000 Corporation Rockville, MD 0000000000
000000000 Angel-Backed Albuquerque, NM 0 00000 000000000. 0 00000
0000000 Formerly VC-backed Lebanon, NH 00 000.00 000000&0 000.00
You’re viewing 5 of 12 competitors. Get the full list »

Vybion Patents

Vybion Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2018204243-A1 Single chain intrabodies that alter huntingtin mutant degradation Granted 29-May-2013 000000000
AU-2014272024-A1 Single chain intrabodies that alter huntingtin mutant degradation Granted 29-May-2013 000000000
CA-2913418-A1 Single chain intrabodies that alter huntingtin mutant degradation Pending 29-May-2013 000000000
AU-2018204243-B2 Single chain intrabodies that alter huntingtin mutant degradation Active 29-May-2013 000000000 0
AU-2014272024-B2 Single chain intrabodies that alter huntingtin mutant degradation Active 29-May-2013 C07K16/18 0

Vybion Executive Team (4)

Name Title Board Seat Contact Info
Rick Hendrick Chief Financial Officer
George Schneider Board Member, Treasurer & Secretary
Lee Henderson Ph.D Founder, Chief Executive Officer, President & Chairman of Board
Martin Eglitis Ph.D Senior Management Advisor
To view Vybion’s complete executive team members history, request access »

Vybion Board Members (4)

Name Representing Role Since
George Schneider Vybion Board Member, Treasurer & Secretary 000 0000
Kenneth Bartels Self Board Member 000 0000
Lee Henderson Ph.D Vybion Founder, Chief Executive Officer, President & Chairman of Board 000 0000
Nitin Parekh Ph.D Self Board Member & Advisor 000 0000
To view Vybion’s complete board members history, request access »

Vybion Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Vybion Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
National Institutes of Health Government 000 0000 000000 0
Qualifying Therapeutic Discovery Project Government 000 0000 000000 0
Cayuga Venture Fund Venture Capital Minority 000 0000 000000 0
To view Vybion’s complete investors history, request access »